liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Can gender difference in prescription drug use be explained by gender-related morbidity?: a study on a Swedish population during 2006
Lund University, Sweden .
Lund University, Sweden .
Linköping University, Department of Medical and Health Sciences, Division of Community Medicine. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Local Health Care Services in West Östergötland, Research & Development Unit in Local Health Care.
Lund University, Sweden Stanford University, CA 94305 USA .
Show others and affiliations
2014 (English)In: BMC Public Health, ISSN 1471-2458, Vol. 14, no 329Article in journal (Refereed) Published
Abstract [en]

Background: It has been reported that there is a difference in drug prescription between males and females. Even after adjustment for multi-morbidity, females tend to use more prescription drugs compared to males. In this study, we wanted to analyse whether the gender difference in drug treatment could be explained by gender-related morbidity. Methods: Data was collected on all individuals 20 years and older in the county of Ostergotland in Sweden. The Johns Hopkins ACG Case-Mix System was used to calculate individual level of multi-morbidity. A report from the Swedish National Institute of Public Health using the WHO term DALY was the basis for gender-related morbidity. Prescription drugs used to treat diseases that mainly affect females were excluded from the analyses. Results: The odds of having prescription drugs for males, compared to females, increased from 0.45 (95% confidence interval (CI) 0.44-0.46) to 0.82 (95% CI 0.81-0.83) after exclusion of prescription drugs that are used to treat diseases that mainly affect females. Conclusion: Gender-related morbidity and the use of anti-conception drugs may explain a large part of the difference in prescription drug use between males and females but still there remains a difference between the genders at 18%. This implicates that it is of importance to take the gender-related morbidity into consideration, and to exclude anti-conception drugs, when performing studies regarding difference in drug use between the genders.

Place, publisher, year, edition, pages
BioMed Central , 2014. Vol. 14, no 329
Keyword [en]
Prescription drugs; Multi-morbidity; Gender difference; Gender-related morbidity
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-106971DOI: 10.1186/1471-2458-14-329ISI: 000335468700001OAI: diva2:721383
Available from: 2014-06-04 Created: 2014-06-02 Last updated: 2014-06-04

Open Access in DiVA

fulltext(245 kB)132 downloads
File information
File name FULLTEXT01.pdfFile size 245 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Borgquist, Lars
By organisation
Division of Community MedicineFaculty of Health SciencesResearch & Development Unit in Local Health Care
In the same journal
BMC Public Health
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 132 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 46 hits
ReferencesLink to record
Permanent link

Direct link